Skip to content

Voluntary Termination of Pregnancy: Comparison of Women's Experiences Depending on the Method Used.

Voluntary Termination of Pregnancy Between 14 and 16 Weeks of Amenorrhea: Comparison of Women's Experiences Depending on the Method Used, Surgical or Medicinal.

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06140069
Acronym
VECUVG
Enrollment
0
Registered
2023-11-18
Start date
2024-12-20
Completion date
2024-12-20
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Voluntary Termination of Pregnancy

Brief summary

Voluntary termination of pregnancy (abortion) is a major current societal issue. This is a very common situation, around 225,000 abortions are carried out every year in France. The French law of March 2, 2022 (no. 2022-295) extended the legal deadline for voluntary termination of pregnancy from 14 to 16 weeks of amenorrhea (SA). The recommendations have not been updated following this legal extension, the centers performing abortions are therefore free regarding the protocol for carrying out these so-called late abortions (between 14 and 16 weeks). There are two pregnancy termination techniques practiced in France: medical or surgical. The drug method consists of drug-induced expulsion of the pregnancy. This method is carried out in the delivery room, and lasts several hours. The surgical method consists of an endouterine aspiration carried out in the operating room, which lasts approximately 30 minutes. At the Toulouse University Hospital, as in many centers in France, it is the patient who chooses the method, apart from a contraindication to one or other of these methods. Due to the recent nature of these late abortions, practitioners still have little experience of the consequences of these procedures and this compromises the quality of the information provided to patients. It is necessary to have quality studies to improve knowledge about late abortions, in order to be able to correctly inform patients and allow them to make an informed choice regarding the method used.

Interventions

OTHERQuestionnaire

A questionnaire is offered to patients who meet the eligibility criteria and who have given their non-objection during the abortion request consultation. This questionnaire includes questions for screening for anxiety and depressive disorders.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any adult patient * Having given her non-opposition after clear and fair information (patient who understands and reads French) * Patient treated at the Toulouse University Hospital for an abortion between 14 and 16 weeks (dating by ultrasound) * Singleton pregnancy * Progressive pregnancy

Exclusion criteria

* Protected adult patient (guardianship, curatorship, protection of justice) * Developing psychiatric pathologies * Fetal anomaly detected

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of anxiety or depressive disorder depending on the method used, surgical or medicinalAt the inclusion visit before abortion and 3 weeks after abortionAnxiety will be measured using Hospital Anxiety and Depression Scale (HADS)

Contacts

PRINCIPAL_INVESTIGATORLola LOUSSERT CHAMBRE, MD

University Hospital, Toulouse

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026